PEOPLE/WEB SEARCH CALENDAR EMERGENCY INFO A-Z INDEX UVA EMAIL
RETURN TO U.VA. INNOVATION SEARCH TECHNOLOGIES ADVANCED
SEARCH
SUBSCRIBE
TO RSS

Search Results - paul+hoffman

2 Results Sort By:
Novel Compounds for the Treatment of Diarrheal Diseases
Executive SummaryUniversity of Virginia researchers have created novel derivative compounds of FDA-approved drug Nitazoxanide (NTZ) that show reduced toxicity, improved bioavailability and greater efficacy against a range of organisms that cause diarrheal diseases. BackgroundDiarrheal diseases are especially common in children, immuno-compromised individuals,...
Published: 3/8/2012   |   Inventor(s): Timothy Macdonald, Richard Guerrant, Paul Hoffman, Thomas Ballard
Keywords(s): Therapeutics
Category(s): Therapeutics
Novel Compounds for Prevention and Treatment of Bacterial Infections and Biofilms
Executive SummaryUniversity of Virginia researchers have created novel derivative compounds of FDA-approved drug Nitazoxanide (NTZ) that show reduced toxicity, improved bioavailability and greater efficacy against bacterial infections and biofilms.BackgroundOpportunistic hospital-acquired pathogens, including S. epidermidis and S. aureus, are the leading...
Published: 3/8/2012   |   Inventor(s): Timothy Macdonald, Richard Guerrant, Paul Hoffman, Thomas Ballard
Keywords(s): Therapeutics
Category(s): Therapeutics
Home | Search | RSS Feed
Maintained by: U.Va. Innovation
© 2012 by the Rector and Visitors of the University of Virginia
All Rights Reserved. Powered by Inteum
U.Va. Innovation
434.924.2175
434.982.1583
250 W. Main St., Ste. 300
P.O. Box 800755
Charlottesville, VA 22902